Antibody Screening & Identification Panels (in Immunohematology)
1. Objective:
To detect and identify unexpected antibodies in a patient’s serum that may react with red blood cell antigens, especially before transfusion.
siza
2. Principle:
Patient serum is mixed with reagent red cells of known antigen profiles. Agglutination indicates the presence of antibodies. Identification involves comparing reaction patterns with known antigen matrices.
3. Materials:
-
Patient serum/plasma
-
Screening and identification red cell panels
-
LISS or saline
-
Antiglobulin reagent (Coombs reagent)
-
Test tubes or gel cards
-
Centrifuge, incubator
4. Procedure:
-
Mix patient serum with screening cells → incubate.
-
Wash to remove unbound antibodies.
-
Add antihuman globulin → check for agglutination.
-
If positive, proceed to identification with an extended red cell panel.
-
Compare agglutination pattern to known antigen profiles.
5. Result Interpretation:
-
No agglutination: No detectable antibodies.
-
Agglutination with specific cells: Suggests presence of particular antibody (e.g., anti-D, anti-K, etc.).
6. Clinical Significance:
-
Crucial in transfusion safety.
-
Prevents hemolytic transfusion reactions.
-
Used in prenatal testing for HDFN (Hemolytic Disease of the Fetus and Newborn).
Comments
Post a Comment